Previous Article | Next Article 
Journal of Virology, May 2000, p. 4505-4511, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus
Stimulation
Ligia A.
Pinto,1
Vesna
Blazevic,1
Bruce K.
Patterson,2
C.
Mac
Trubey,3
Matthew J.
Dolan,4 and
Gene M.
Shearer1,*
Experimental Immunology Branch, National
Cancer Institute, National Institutes of Health,
Bethesda,1 andIntramural Research
Support Program, SAIC Frederick, NCI-FCRDC,
Frederick,3 Maryland; Laboratory of
Viral Pathogenesis, Northwestern University Medical School, Chicago,
Illinois2; and Wilford Hall Medical
Center, Lackland AFB, Texas4
Received 27 September 1999/Accepted 11 February 2000
It is now recognized that, in addition to drug-mediated therapies
against human immunodeficiency virus type 1 (HIV-1), the immune system
can exert antiviral effects via CD8+ T-cell-generated
anti-HIV factors. This study demonstrates that (i) supernatants from
peripheral blood mononuclear cells (PBMC) stimulated with influenza A
virus inhibit replication of CCR5- and CXCR4-tropic HIV-1 isolates
prior to reverse transcription; (ii) the HIV-suppressive supernatants
can be generated by CD4- or CD8-depleted PBMC; (iii) this anti-HIV
activity is partially due to alpha interferon (IFN-
), but not to
IFN-
, IFN-
, the
-chemokines MIP-1
, MIP-1
, and RANTES, or
interleukin-16; (iv) the anti-HIV activity is generated equally well by
PBMC cultured with either infectious or UV-inactivated influenza A
virus; and (v) the antiviral activity can be generated by influenza
A-stimulated PBMC from HIV-infected individuals. These findings
represent a novel mechanism for inhibition of HIV-1 replication that
differs from the previously described CD8 anti-HIV factors (MIP-1
,
MIP-1
, RANTES, and CD8 antiviral factor).
*
Corresponding author. Mailing address: Experimental
Immunology Branch, National Institutes of Health, NCI, Bldg. 10, Rm.
4B36, Bethesda, MD 20892. Phone: (301) 402-3246. Fax: (301) 402-3643. E-mail: shearerg{at}exchange.nih.gov.
Journal of Virology, May 2000, p. 4505-4511, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O., Mammano, F.
(2009). Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer. J. Virol.
83: 10527-10537
[Abstract]
[Full Text]
-
Fakruddin, J. M., Lempicki, R. A., Gorelick, R. J., Yang, J., Adelsberger, J. W., Garcia-Pineres, A. J., Pinto, L. A., Lane, H. C., Imamichi, T.
(2007). Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood
109: 1841-1849
[Abstract]
[Full Text]
-
Pilotti, E., Elviri, L., Vicenzi, E., Bertazzoni, U., Re, M. C., Allibardi, S., Poli, G., Casoli, C.
(2007). Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. Blood
109: 1850-1856
[Abstract]
[Full Text]
-
Gould, S. J., Booth, A. M., Hildreth, J. E. K.
(2003). The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA
100: 10592-10597
[Abstract]
[Full Text]
-
Mazzoni, A., Leifer, C. A., Mullen, G. E. D., Kennedy, M. N., Klinman, D. M., Segal, D. M.
(2003). Cutting Edge: Histamine Inhibits IFN-{alpha} Release from Plasmacytoid Dendritic Cells. J. Immunol.
170: 2269-2273
[Abstract]
[Full Text]
-
Rice, J., Connor, R., Worgall, S., Moore, J. P., Leopold, P. L., Kaner, R. J., Crystal, R. G.
(2002). Inhibition of HIV-1 Replication in Alveolar Macrophages by Adenovirus Gene Transfer Vectors. Am. J. Respir. Cell Mol. Bio.
27: 214-219
[Abstract]
[Full Text]
-
Chang, T. L.-Y., Mosoian, A., Pine, R., Klotman, M. E., Moore, J. P.
(2002). A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation. J. Virol.
76: 569-581
[Abstract]
[Full Text]
-
Xiang, J., Wunschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L., Stapleton, J. T.
(2001). Effect of Coinfection with GB Virus C on Survival among Patients with HIV Infection. NEJM
345: 707-714
[Abstract]
[Full Text]
-
Bahr, G. M., Darcissac, E. C. A., Casteran, N., Amiel, C., Cocude, C., Truong, M.-J., Dewulf, J., Capron, A., Mouton, Y.
(2001). Selective Regulation of Human Immunodeficiency Virus-Infected CD4+ Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice. J. Virol.
75: 6941-6952
[Abstract]
[Full Text]